Fluvastatin and Gemcitabine in Pancreatic Cancer
Author Information
Author(s): Bocci G, Fioravanti A, Orlandi P, Bernardini N, Collecchi P, Del Tacca M, Danesi R
Primary Institution: University of Pisa
Hypothesis
Can fluvastatin enhance the effectiveness of gemcitabine in treating pancreatic cancer cells?
Conclusion
The combination of fluvastatin and gemcitabine is an effective treatment against pancreatic cancer cells, significantly enhancing cytotoxic effects and inducing apoptosis.
Supporting Evidence
- Fluvastatin inhibits proliferation and induces apoptosis in pancreatic cancer cells.
- The combination treatment resulted in significant tumor growth suppression in animal models.
- Fluvastatin enhances the expression of the enzyme needed to activate gemcitabine.
Takeaway
Fluvastatin, a cholesterol-lowering drug, can help make a cancer drug called gemcitabine work better against pancreatic cancer cells.
Methodology
The study involved in vitro and in vivo experiments on MIAPaCa-2 pancreatic cancer cells, assessing the effects of fluvastatin and gemcitabine on cell proliferation and apoptosis.
Limitations
The study primarily focused on in vitro and animal models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website